Revolutions Medical has signed Letter of Intent with Medical Investment Group (MIG) for the manufacturing of the RevVac 3cc safety syringe.
Under the terms of agreement, manufacturing of 5 million syringes per month is expected. The agreed upon general terms allows an increase of up to 20 million syringes per month through MIG’s both domestic and international manufacturing capabilities.
Revolutions Medical is a safety medical device and software application company with products including the RevVac safety syringe (FDA approved), safety blood drawing device and safety IV catheter.
The company also provides RevColor, RevDisplay and Rev3D software solutions and proprietary tools that are compatible with standard MRIs and standard PACS.
The final terms are expected to be completed in definitive documents between the parties no later than 17 September 2010.